The FDA clarifies its interpretation of “more effective” and indicates it will consider improved accessibility of a device during the Breakthrough designation process.
FDA releases updated final guidance for its Breakthrough Devices Program
The FDA clarifies its interpretation of “more effective” and indicates it will consider improved accessibility of a device during the Breakthrough designation process.
